Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Feb 5;10(4):611.
doi: 10.3390/jcm10040611.

The Challenging Road to Hepatitis C Virus Eradication

Isidoro Martínez  1 , Pablo Ryan  2 , Jorge Valencia  2   3 , Salvador Resino  1
Affiliations
Editorial

The Challenging Road to Hepatitis C Virus Eradication

Isidoro Martínez et al. J Clin Med. .

Abstract

Hepatitis C virus (HCV) infection remains a substantial health problem as a leading cause of chronic liver disease worldwide [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. The Polaris Observatory HCV Collaborators Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol. Hepatol. 2017;2:161–176. doi: 10.1016/S2468-1253(16)30181-9. - DOI - PubMed
    1. Westbrook R.H., Dusheiko G. Natural history of hepatitis C. J. Hepatol. 2014;61:S58–S68. doi: 10.1016/j.jhep.2014.07.012. - DOI - PubMed
    1. Morris M.D., Shiboski S., Bruneau J., Hahn J.A., Hellard M., Prins M., Cox A.L., Dore G., Grebely J., Kim A.Y., et al. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin. Infect. Dis. 2017;64:860–869. doi: 10.1093/cid/ciw869. - DOI - PMC - PubMed
    1. Day E., Hellard M., Treloar C., Bruneau J., Martin N.K., Ovrehus A., Dalgard O., Lloyd A., Dillon J., Hickman M., et al. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver Int. Off. J. Int. Assoc. Study Liver. 2019;39:20–30. doi: 10.1111/liv.13949. - DOI - PMC - PubMed
    1. Valencia J., Alvaro-Meca A., Troya J., Cuevas G., Gutierrez J., Morro A., Alvarez J., Pulido L., Canamares I., Escobar I., et al. High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units. Int. J. Drug Policy. 2019;72:181–188. doi: 10.1016/j.drugpo.2019.06.016. - DOI - PubMed

Publication types